Peers of Beam Therapeutics Inc (BEAM)
Side-by-side comparison
Health Care · Biotechnology
Market cap divided by sales over the last 12 months. Useful for companies that aren’t profitable yet.
Latest P/S Ratio
16.27x
As of Oct 22, 2026
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Oct 22, 2026 | 16.27x |
| Oct 21, 2026 | 16.44x |
| Oct 20, 2026 | 16.50x |
| Oct 19, 2026 | 16.01x |
| Oct 16, 2026 | 15.53x |
| Oct 15, 2026 | 16.37x |
| Oct 14, 2026 | 15.65x |
| Oct 13, 2026 | 16.17x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison